Cited by 166Nutrition and Health in AgingMuscle Physiology and DisordersBody Composition Measurement Techniques

The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.

Circulating irisin levels as a predictive biomarker for sarcopenia: a cross-sectional community-based study

Open access

Chang, Jae Seung, Kim, Tae Ho, Nguyen, Tuyet Thi, Park, Kyu‐Sang, Kim, Nahyun, Kong, In Deok·2017·Geriatrics & Gerontology International

DOI 10.1111/ggi.13030

Open this paper in CoChat — free account Open PDF

Abstract

Aim: Myokines are peptides released by the skeletal muscle, and have gained popularity as potential biomarkers for sarcopenia. Irisin is a recently identified myokine, but its role in pathological sarcopenia remains unclear. We investigated the validity and accuracy of circulating irisin levels as a potential biomarker for sarcopenia. Methods: We evaluated the anthropometrics, body composition, sarcopenia‐related parameters and serum irisin levels of 715 community‐dwelling Koreans. Sarcopenia was determined on the basis of the clinical diagnostic criteria of muscle atrophy and weakness, which were proposed by the Asian Working Group for Sarcopenia. Results: Circulating irisin levels were correlated with appendicular lean mass/height 2 (rmen = 0.275; rwomen = 0.321) and handgrip strength (rmen = 0.219; rwomen = 0.312) in both sexes (all P < 0.01). Furthermore, the mean circulating irisin levels were lower in the sarcopenia group than in the normal group (all P < 0.05). In the logistic regression models, the association between serum irisin concentration and incident sarcopenia persisted even after adjusting for potential confounders, such as sex, age and fat indices (odds ratio 0.20, 95% CI 0.07–0.60; P for trend <0.01). The predictive values of serum irisin for sarcopenia were <1.0 μg/mL in men and <1.16 μg/mL in women, with the area under the receiver operating characteristic curves of 0.87 (95% CI 0.77–0.99) and 0.68 (95% CI 0.55–0.81), respectively (all P < 0.01). Conclusions: A low level of circulating irisin is a sensitive marker for muscle weakness and atrophy. Irisin is a potential biomarker for muscle dysfunction that could help predict the onset of sarcopenia and provide new avenues for monitoring age‐related muscle changes. Geriatr Gerontol Int 2017; 17: 2266–2273.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1111/ggi.13030

Cites

33 of 33 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework
Biomarkers Definitions Working Group (2001) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2001.113989 · Cited by 6,771
A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis
Boström, P., Wu, J., Jedrychowski, M. P., Korde, A., Ye, L., Lo, J. C., Rasbach, K. A., Boström, E. A., Choi, J. H., Long, J. Z., et al. (2012) · Nature · doi:10.1038/nature10777 · Cited by 4,810
Sarcopenia in Asia: Consensus Report of the Asian Working Group for Sarcopenia
Chen, L.-K., Liu, L.-K., Woo, J., Assantachai, P., Auyeung, T.-W., Bahyah, K. S., Chou, M.-Y., Chen, L.-Y., Hsu, P.-S., Krairit, O., et al. (2014) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2013.11.025 · Cited by 4,051
The Loss of Skeletal Muscle Strength, Mass, and Quality in Older Adults: The Health, Aging and Body Composition Study
Goodpaster, B. H., Park, S. W., Harris, T. B., Kritchevsky, S. B., Nevitt, M., Schwartz, A. V., Simonsick, E. M., Tylavsky, F. A., Visser, M., Newman, A. B., et al. (2006) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/61.10.1059 · Cited by 3,083
Muscles, exercise and obesity: skeletal muscle as a secretory organ
Pedersen, B. K., & Febbraio, M. A. (2012) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2012.49 · Cited by 2,909
Bioelectrical impedance analysis—part II: utilization in clinical practice
Kyle, U. G., Bosaeus, I., De Lorenzo, A. D., Deurenberg, P., Elia, M., Manuel Gómez, J., Lilienthal Heitmann, B., Kent-Smith, L., Melchior, J.-C., Pirlich, M., et al. (2004) · Clinical Nutrition · doi:10.1016/j.clnu.2004.09.012 · Cited by 2,350
Inflammatory markers and loss of muscle mass (sarcopenia) and strength
Schaap, L. A., Pluijm, S. M. F., Deeg, D. J. H., & Visser, M. (2006) · The American Journal of Medicine · doi:10.1016/j.amjmed.2005.10.049 · Cited by 1,047
FNDC5 and Irisin in Humans: I. Predictors of Circulating Concentrations in Serum and Plasma and II. mRNA Expression and Circulating Concentrations in Response to Weight Loss and Exercise
Huh, J. Y., Panagiotou, G., Mougios, V., Brinkoetter, M., Vamvini, M. T., Schneider, B. E., & Mantzoros, C. S. (2012) · Metabolism · doi:10.1016/j.metabol.2012.09.002 · Cited by 1,040
FNDC5/irisin is not only a myokine but also an adipokine
Roca-Rivada, A., Castelao, C., Senin, L. L., Landrove, M. O., Baltar, J., Crujeiras, A. B., Seoane, L. M., Casanueva, F. F., & Pardo, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0060563 · Cited by 612
Review Article: Sarcopenia: Causes, Consequences, and Preventions
Marcell, T. J. (2003) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/58.10.m911 · Cited by 536

Show all 33 references

Sorted by citations

Asian Working Group for Sarcopenia: 2019 Consensus Update on Sarcopenia Diagnosis and Treatment
Chen, L.-K., Woo, J., Assantachai, P., Auyeung, T.-W., Chou, M.-Y., Iijima, K., Jang, H. C., Kang, L., Kim, M., Kim, S., et al. (2020) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2019.12.012 · Cited by 7,070
Towards frailty biomarkers: Candidates from genes and pathways regulated in aging and age-related diseases
Cardoso, A. L., Fernandes, A. M. A., Aguilar‐Pimentel, J. A., de Angelis, M. H., Guedes, J. R., Brito, M. A., Ortolano, S., Pani, G., Athanasopoulou, S., Gonos, E. S., et al. (2018) · Ageing Research Reviews · doi:10.1016/j.arr.2018.07.004 · Cited by 483
Biomarkers of aging
Bao, H., Cao, J., Chen, M., Min, C., Chen, W., Chen, X., Chen, Y., Chen, Y., Chen, Y., Chen, Z., et al. (2023) · Science China Life Sciences · doi:10.1007/s11427-023-2305-0 · Cited by 402
Sarcopenic obesity in older adults: a clinical overview
Prado, C. M., Batsis, J. A., Donini, L. M., Gonzalez, M. C., & Siervo, M. (2024) · Nature Reviews Endocrinology · doi:10.1038/s41574-023-00943-z · Cited by 355
Irisin: A Hope in Understanding and Managing Obesity and Metabolic Syndrome
Arhire, L. I., Mihalache, L., & Covașă, M. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00524 · Cited by 317
Hepatic Selective Insulin Resistance at the Intersection of Insulin Signaling and Metabolic Dysfunction-Associated Steatotic Liver Disease
Bo, T., Gao, L., Yao, Z., Shao, S., Wang, X., Proud, C. G., & Zhao, J. (2024) · Cell Metabolism · doi:10.1016/j.cmet.2024.04.006 · Cited by 293
Multifactorial Mechanism of Sarcopenia and Sarcopenic Obesity. Role of Physical Exercise, Microbiota and Myokines
Bilski, J., Pierzchalski, P., Szczepanik, M., Bonior, J., & Zoladz, J. A. (2022) · Cells · doi:10.3390/cells11010160 · Cited by 271
Diabetes and Sarcopenic Obesity: Pathogenesis, Diagnosis, and Treatments
Wang, M., Tan, Y., Shi, Y., Wang, X., Liao, Z., & Wei, P. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00568 · Cited by 231
Inflammaging: Implications in Sarcopenia
Antuña, E., Cachán-Vega, C., Bermejo-Millo, J. C., Potes, Y., Caballero, B., Vega‐Naredo, I., Coto‐Montes, A. M., & García-González, C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232315039 · Cited by 234
Sarcopenic obesity
Polyzos, S. A., & Margioris, A. N. (2018) · Hormones · doi:10.1007/s42000-018-0049-x · Cited by 212
Role of irisin in physiology and pathology
Liu, S., Cui, F., Ning, K., Wang, Z., Fu, P., Wang, D., & Xu, H. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.962968 · Cited by 186
Exercise therapy for people with sarcopenic obesity: myokines and adipokines as effective actors
Alizadeh Pahlavani, H. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.811751 · Cited by 145
Sarcopenia and fatty liver disease
Kim, J. A., & Choi, K. M. (2019) · Hepatology International · doi:10.1007/s12072-019-09996-7 · Cited by 125
Bone and Muscle Crosstalk in Aging
He, C., He, W., Hou, J., Chen, K., Huang, M., Yang, M., Luo, X., & Li, C. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.585644 · Cited by 129
Exercise-Induced Myokines can Explain the Importance of Physical Activity in the Elderly: An Overview
Kwon, J. H., Moon, K. M., & Min, K.-W. (2020) · Healthcare · doi:10.3390/healthcare8040378 · Cited by 116
Inactivity and Skeletal Muscle Metabolism: A Vicious Cycle in Old Age
Rezuş, E., Burlui, A., Cardoneanu, A., Rezuș, C., Codreanu, C., Parvu, M., Zota, G. R., & Tamba, B.-I. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21020592 · Cited by 122
The Vicious Cycle of Myostatin Signaling in Sarcopenic Obesity: Myostatin Role in Skeletal Muscle Growth, Insulin Signaling and Implications for Clinical Trials
Consitt, L. A., & Clark, B. C. (2018) · The Journal of Frailty & Aging · doi:10.14283/jfa.2017.33 · Cited by 122
The novel myokine irisin: clinical implications and potential role as a biomarker for sarcopenia in postmenopausal women
Park, H., Kim, H. C., Zhang, D., Yeom, H., & Lim, S.-K. (2018) · Endocrine · doi:10.1007/s12020-018-1814-y · Cited by 112
Biological Aspects of Selected Myokines in Skeletal Muscle: Focus on Aging
Mancinelli, R., Checcaglini, F., Coscia, F., Gigliotti, P. V., Fulle, S., & Fanò, G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22168520 · Cited by 113
Prediction of sarcopenia using a battery of circulating biomarkers
Qaisar, R., Karim, A., Muhammad, T., Shah, I., & Khan, J. (2021) · Scientific Reports · doi:10.1038/s41598-021-87974-6 · Cited by 103
Is irisin the new player in exercise-induced adaptations or not? A 2017 update
Fatouros, I. G. (2017) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2017-0674 · Cited by 95
Sarcopenia, sarcopenic obesity and nonalcoholic fatty liver disease.
Polyzos, S., Vachliotis, I. D., & Mantzoros, C. (2023) · Metabolism: Clinical and Experimental · doi:10.1016/j.metabol.2023.155676 · Cited by 83
Searching for the link between inflammaging and sarcopenia
Wang, T. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101611 · Cited by 90
Sarcopenic obesity: Myokines as potential diagnostic biomarkers and therapeutic targets?
Guo, A., Li, K., & Xiao, Q. (2020) · Experimental Gerontology · doi:10.1016/j.exger.2020.111022 · Cited by 83
Non-alcoholic fatty liver disease-related fibrosis and sarcopenia: An altered liver-muscle crosstalk leading to increased mortality risk
Kuchay, M. S., Martínez‐Montoro, J. I., Kaur, P., Fernández‐García, J. C., & Ramos‐Molina, B. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101696 · Cited by 86
Blood biomarkers for sarcopenia: A systematic review and meta-analysis of diagnostic test accuracy studies
Lian, R., Liu, Q., Jiang, G., Zhang, X., Tang, H., Lü, J., & Yang, M. J. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.102148 · Cited by 86
Biochemical Markers of Musculoskeletal Health and Aging to be Assessed in Clinical Trials of Drugs Aiming at the Treatment of Sarcopenia: Consensus Paper from an Expert Group Meeting Organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and the Centre Académique de Recherche et d'Expérimentation en Santé (CARES SPRL), Under the Auspices of the World Health Organization Collaborating Center for the Epidemiology of Musculoskeletal Conditions and Aging
Ladang, A., Beaudart, C., Reginster, J., Al‐Daghri, N. M., Bruyère, O., Burlet, N., Cesari, M., Cherubini, A., da Silva, M. C., Cooper, C. C., et al. (2023) · Calcified Tissue International · doi:10.1007/s00223-022-01054-z · Cited by 85
South Asian Working Action Group on SARCOpenia (SWAG-SARCO) – A consensus document
Dhar, M., Kapoor, N., Suastika, K., Khamseh, M. E., Selim, S., Kumar, V., Raza, S. A., Azmat, U., Pathania, M., Mahadeb, Y., et al. (2022) · Osteoporosis and Sarcopenia · doi:10.1016/j.afos.2022.04.001 · Cited by 80
Circulating Irisin and Myostatin as Markers of Muscle Strength and Physical Condition in Elderly Subjects
Planella-Farrugia, C., Comas, F., Sabater, M., Moreno, M., Moreno‐Navarrete, J. M., Rovira, O., Ricart, W., & Fernández‐Real, J. M. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.00871 · Cited by 77
Muscle-bone crosstalk via endocrine signals and potential targets for osteosarcopenia-related fracture
Sheng, R., Cao, M., Song, M., Wang, M., Zhang, Y., Shi, L., Xie, T., Li, Y., Wang, J., & Rui, Y. (2023) · Journal of Orthopaedic Translation · doi:10.1016/j.jot.2023.09.007 · Cited by 85
Irisin prevents dexamethasone-induced atrophy in C2C12 myotubes
Chang, J. S., & Kong, I. D. (2020) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-020-02367-4 · Cited by 74
Self-citation
Pathophysiology of sarcopenia: Genetic factors and their interplay with environmental factors
Aslam, M. A., Ma, E. B., & Huh, J. Y. (2023) · Metabolism · doi:10.1016/j.metabol.2023.155711 · Cited by 76
Handgrip strength is inversely associated with metabolic syndrome and its separate components in middle aged and older adults: a large-scale population-based study
Wu, H., Liu, M., Quynh, V. T., Wang, J., Zhang, Q., Liu, L., Meng, G., Yao, Z., Bao, X., Gu, Y., et al. (2019) · Metabolism · doi:10.1016/j.metabol.2019.01.011 · Cited by 69
Circulating Biomarkers of Accelerated Sarcopenia in Respiratory Diseases
Qaisar, R., Karim, A., Muhammad, T., & Shah, I. (2020) · Biology · doi:10.3390/biology9100322 · Cited by 68
Decreased Concentration of Irisin Is Associated with Poor Functional Outcome in Ischemic Stroke
Tu, W., Qiu, H., Cao, J., Liu, Q., Zeng, X., & Zhao, J.-Z. (2018) · Neurotherapeutics · doi:10.1007/s13311-018-0651-2 · Cited by 69
Skeletal muscle and MASLD: Mechanistic and clinical insights
Marjot, T., Armstrong, M. J., & Stine, J. G. (2025) · Hepatology Communications · doi:10.1097/hc9.0000000000000711 · Cited by 76
Adipose–Muscle Crosstalk in Age-Related Metabolic Disorders: The Emerging Roles of Adipo-Myokines
Fang, P., She, Y., Yu, M., Min, W., Shang, W., & Zhang, Z. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101829 · Cited by 62
Ageing of skeletal muscle extracellular matrix and mitochondria: finding a potential link
Cai, L., Shi, L., Peng, Z., Sun, Y., & Chen, J. (2023) · Annals of Medicine · doi:10.1080/07853890.2023.2240707 · Cited by 63
Effect of Chronic Resistance Training on Circulating Irisin: Systematic Review and Meta-Analysis of Randomized Controlled Trials
Cosio, P. L., Crespo-Posadas, M., Velarde-Sotres, Á., & Pelaez, M. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18052476 · Cited by 56
Myokine-mediated muscle-organ interactions: Molecular mechanisms and clinical significance
Yi, J., Chen, J., Yao, X., Zhao, Z., Niu, X., Li, X., Sun, J., Ji, Y., Shang, T., Gong, L., et al. (2025) · Biochemical Pharmacology · doi:10.1016/j.bcp.2025.117326 · Cited by 68
Association between serum irisin concentrations and sarcopenia in patients with liver cirrhosis: a cross-sectional study
Zhao, M., Zhou, X., Yuan, C., Li, R., Ma, Y., & Tang, X. (2020) · Scientific Reports · doi:10.1038/s41598-020-73176-z · Cited by 53
Molecular mechanisms and therapeutic interventions in sarcopenia
Park, S. S., Kwon, E., & Kwon, K. (2017) · Osteoporosis and Sarcopenia · doi:10.1016/j.afos.2017.08.098 · Cited by 52
The Impact of Dysmetabolic Sarcopenia Among Insulin Sensitive Tissues: A Narrative Review
Armandi, A., Rosso, C., Caviglia, G. P., Ribaldone, D. G., & Bugianesi, E. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.716533 · Cited by 48
Proteomic serum biomarkers for neuromuscular diseases
Murphy, S., Zweyer, M., Mundegar, R. R., Swandulla, D., & Ohlendieck, K. (2018) · Expert Review of Proteomics · doi:10.1080/14789450.2018.1429923 · Cited by 47
Sarcopenia and cachexia: molecular mechanisms and therapeutic interventions
Wang, T., Zhou, D., & Hong, Z. (2025) · MedComm · doi:10.1002/mco2.70030 · Cited by 46
Irisin is a predictor of sarcopenic obesity in type 2 diabetes mellitus
Oğuz, A., Şahin, M., Tüzün, D., Kurutaş, E. B., Ülgen, C., Bozkus, O., & Gül, K. (2021) · Medicine · doi:10.1097/md.0000000000026529 · Cited by 46
Nonalcoholic fatty liver disease in the over-60s: Impact of sarcopenia and obesity
Wijarnpreecha, K., Panjawatanan, P., Aby, E., Ahmed, A., & Kim, D. (2019) · Maturitas · doi:10.1016/j.maturitas.2019.03.016 · Cited by 32
Musculoskeletal health in children and adolescents
Faienza, M. F., Urbano, F., Chiarito, M., Lassandro, G., & Giordano, P. (2023) · Frontiers in Pediatrics · doi:10.3389/fped.2023.1226524 · Cited by 48
Screening for Sarcopenia among Elderly Arab Females: Influence of Body Composition, Lifestyle, Irisin, and Vitamin D
Alsaawi, T. A., Aldisi, D. A., Abulmeaty, M. M. A., Khattak, M. N. K., Alnaami, A. M., Sabico, S., & Al‐Daghri, N. M. (2022) · Nutrients · doi:10.3390/nu14091855 · Cited by 37
Energy metabolism and frailty: The potential role of exercise-induced myokines – A narrative review
Barros, D. G. M., Marques, E. A., Magalhães, J., & Carvalho, J. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101780 · Cited by 41
Serum irisin and myostatin levels after 2 weeks of high-altitude climbing
Śliwicka, E., Cisoń, T., Kasprzak, Z., Nowak, A., & Pilaczyńska-Szczȩśniak, Ł. (2017) · PLoS ONE · doi:10.1371/journal.pone.0181259 · Cited by 36
A Multifactorial Approach for Sarcopenia Assessment: A Literature Review
Supriya, R., Singh, K. P., Gao, Y., Li, F., Dutheil, F., & Baker, J. S. (2021) · Biology · doi:10.3390/biology10121354 · Cited by 40
Association between sarcopenia and osteoarthritis among the US adults: a cross-sectional study
Peng, P., Wu, J., Fang, W., Tian, J., He, M., Xiao, F., Lin, K. C., Xu, X., He, W., Liu, W., et al. (2024) · Scientific Reports · doi:10.1038/s41598-023-50528-z · Cited by 35
Forgot to Exercise? Exercise Derived Circulating Myokines in Alzheimer's Disease: A Perspective
Gupta, R., Khan, R., & Cortés, C. J. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2021.649452 · Cited by 37
Implication of diet and exercise on the management of age‐related sarcopenic obesity in Asians
Kim, Y. J., Moon, S., Yu, J. M., & Chung, H. S. (2022) · Geriatrics and gerontology international/Geriatrics & gerontology international · doi:10.1111/ggi.14442 · Cited by 36
Serum irisin level is independent of sarcopenia and related muscle parameters in older adults
Baek, J. Y., Jang, I., Jung, H., Park, S. J., Lee, J. Y., Choi, E., Lee, Y. S., Lee, E., & Kim, B. (2022) · Experimental Gerontology · doi:10.1016/j.exger.2022.111744 · Cited by 39
Crosstalk between Irisin Levels, Liver Fibrogenesis and Liver Damage in Non-Obese, Non-Diabetic Individuals with Non-Alcoholic Fatty Liver Disease
Armandi, A., Rosso, C., Nicolosi, A., Caviglia, G. P., Abate, M. L., Olivero, A., D’Amato, D., Vernero, M., Gaggini, M., Saracco, G. M., et al. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11030635 · Cited by 32
The interplay between muscle mass decline, obesity, and type 2 diabetes
Maliszewska, K., Adamska-Patruno, E., & Kretowski, A. J. (2019) · Polskie Archiwum Medycyny Wewnętrznej · doi:10.20452/pamw.15025 · Cited by 35
Identification of Coenzyme Q10 and Skeletal Muscle Protein Biomarkers as Potential Factors to Assist in the Diagnosis of Sarcopenia
Yen, C., Chang, P., Chang, Y., & Lin, P. (2022) · Antioxidants · doi:10.3390/antiox11040725 · Cited by 30
Complex Exercise Improves Anti-Inflammatory and Anabolic Effects in Osteoarthritis-Induced Sarcopenia in Elderly Women
Park, J., Bae, J.-J., & Lee, J. (2021) · Healthcare · doi:10.3390/healthcare9060711 · Cited by 28
Are Skeletal Muscle Changes during Prolonged Space Flights Similar to Those Experienced by Frail and Sarcopenic Older Adults?
Cannavò, A., Carandina, A., Corbi, G., Tobaldini, E., Montano, N., & Arosio, B. (2022) · Life · doi:10.3390/life12122139 · Cited by 29
Pathophysiological interactions between sarcopenia and type 2 diabetes: A two‐way street influencing diagnosis and therapeutic options
Tack, W., Cock, A. D., Dirinck, E. L., Bastijns, S., Ariën, F., & Perkisas, S. (2023) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15321 · Cited by 34
Dulaglutide Protects Mice against Diabetic Sarcopenia-Mediated Muscle Injury by Inhibiting Inflammation and Regulating the Differentiation of Myoblasts
Deng, F., Wu, W., Fan, X., Zhong, X., Wang, N., Wang, Y., Pan, T., & Du, Y. (2023) · International Journal of Endocrinology · doi:10.1155/2023/9926462 · Cited by 26
Identification of frailty and sarcopenia in hospitalised older people
Echeverria, I., Besga, A., Sanz, B., Amasene, M., Hervás, G., Barroso, J., Rodriguez‐Larrad, A., & Irazusta, J. (2020) · European Journal of Clinical Investigation · doi:10.1111/eci.13420 · Cited by 24
Irisin Serum Levels and Skeletal Muscle Assessment in a Cohort of Charcot-Marie-Tooth Patients
Colaianni, G., Oranger, A., Dicarlo, M., Lovero, R., Storlino, G., Pignataro, P., Fontana, A., Serio, F. D., Ingravallo, A., Caputo, G., et al. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.886243 · Cited by 25
Biomarkers of sarcopenia: an unmet need
Sebaie, M. A. E., & Elwakil, W. (2023) · Egyptian Rheumatology and Rehabilitation · doi:10.1186/s43166-023-00213-w · Cited by 25
A framework of biomarkers for skeletal muscle aging: a consensus statement by the Aging Biomarker Consortium
Huang, N., Ge, M., Liu, X., Tian, X., Yin, P., Bao, Z., Cao, F., Shyh‐Chang, N., Dong, B., Dai, L., et al. (2024) · Life Medicine · doi:10.1093/lifemedi/lnaf001 · Cited by 27
The relationship between sarcopenia detected in newly diagnosed colorectal cancer patients and FGF21, irisin and CRP levels
Oflazoğlu, U., Cağlar, S., Yılmaz, H. E., Önal, H. T., Varol, U., Salman, T., Yıldız, Y., Ünal, S., Güç, Z. G., Küçükzeybek, Y., et al. (2022) · European Geriatric Medicine · doi:10.1007/s41999-022-00635-3 · Cited by 23
Irisin and Its Role in Postmenopausal Osteoporosis and Sarcopenia
Falsetti, I., Palmini, G., Donati, S., Aurilia, C., Iantomasi, T., & Brandi, M. L. (2024) · Biomedicines · doi:10.3390/biomedicines12040928 · Cited by 23
Definition and diagnosis of sarcopenia: Asia-Pacific perspectives
Huang, W.-F., Chen, Y., Chang, C., & Wu, C. (2025) · Osteoporosis and Sarcopenia · doi:10.1016/j.afos.2025.05.004 · Cited by 25
Some clarifications of terminology may facilitate sarcopenia assessment
Lewandowicz, A., Slawinski, P. R., Kądalska, E., & Targowski, T. (2020) · Archives of Medical Science · doi:10.5114/aoms.2020.91293 · Cited by 22
New Biomarkers to Evaluate Hyperandrogenemic Women and Hypogonadal Men
Karakas, S. E., & Surampudi, P. N. (2018) · Advances in clinical chemistry · doi:10.1016/bs.acc.2018.06.001 · Cited by 23
Hippocampal injection of the exercise-induced myokine irisin suppresses acute stress-induced neurobehavioral impairment in a sex-dependent manner.
Farshbaf, M. J., Garasia, S., Moussoki, D. P. K., Mondal, A. K., Cherkowsky, D., Manal, N., & Alviña, K. (2020) · Behavioral Neuroscience · doi:10.1037/bne0000367 · Cited by 23
Irisin in Liver Cirrhosis
Kukla, M., Skladaný, Ľ., Menżyk, T., Derra, A., Stygar, D. M., Skonieczna, M., Hudy, D., Nabrdalik, K., Gumprecht, J., Marlicz, W. M., et al. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9103158 · Cited by 21
DNA methylation of skeletal muscle function‐related secretary factors identifies FGF2 as a potential biomarker for sarcopenia
Li, J., Shen, Z., Lin, Y., Wang, Z., Li, M., Sun, H., Wang, Q., Zhao, C., Xu, J., Lü, X., et al. (2024) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.13472 · Cited by 21
Identification of traumatic acid as a potential plasma biomarker for sarcopenia using a metabolomics‐based approach
Tsai, J., Wang, S., Chang, C., Chen, C., Wen, C., Chen, G., Kuo, C., Tseng, Y. J., & Chen, C. (2021) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.12895 · Cited by 20
Unlocking the Therapeutic Potential of Irisin: Harnessing Its Function in Degenerative Disorders and Tissue Regeneration
Zhang, Y., Wang, L., Kang, H., Lin, C.-Y. J., & Fan, Y. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24076551 · Cited by 21
Irisin improves adiposity and exercise tolerance in a rat model of postmenopausal obesity through enhancing adipo-myocyte thermogenesis
Gheit, R. E. A. E., Younis, R. L., El‐Saka, M. H., Emam, M. N., Soliman, N. A., El‐Sayed, R. M., Hafez, Y. M., AbuoHashish, N. A., Radwan, D. A., Khaled, H. E., et al. (2022) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-022-00915-3 · Cited by 20
Irisin and Bone in Sickness and in Health: A Narrative Review of the Literature
Tsourdi, E. A., Anastasilakis, A. D., Hofbauer, L. C., Rauner, M., & Lademann, F. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11226863 · Cited by 19
Irisin Ameliorated Skeletal Muscle Atrophy by Inhibiting Fatty Acid Oxidation and Pyroptosis Induced by Palmitic Acid in Chronic Kidney Disease
Zhou, T., Wang, S., Pan, Y., Dong, X., Wu, L., Meng, J., Zhang, J., Pang, Q., & Zhang, A. (2023) · Kidney & Blood Pressure Research · doi:10.1159/000533926 · Cited by 19
Unlocking diagnosis of sarcopenia: The role of circulating biomarkers – A clinical systematic review
Veronesi, F., Salamanna, F., Borsari, V., Ruffilli, A., Faldini, C., & Giavaresi, G. (2024) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2024.112005 · Cited by 20
Diabetes Mellitus Should Be Considered While Analysing Sarcopenia-Related Biomarkers
Rentflejsz, J., & Wojszel, Z. B. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13041107 · Cited by 18
Association of Irisin Serum Concentration and Muscle Strength in Normal-Weight and Overweight Young Women
Muñoz, I. Y. M., Camarillo-Romero, E. D. S., Padilla, T. C., Benítez, J. G. S., Romero, M. D. S. C., Morales, L. P. M., Bravo, G. G. H., & Garduño‐García, J. D. J. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00621 · Cited by 16
The Influence of Irisin on Selected Organs—The Liver, Kidneys, and Lungs: The Role of Physical Exercise
Ciałowicz, M., Woźniewski, M., Murawska‐Ciałowicz, E., & Dzięgiel, P. (2025) · Cells · doi:10.3390/cells14161228 · Cited by 17
Circulating Irisin Is Reduced in Male Patients with Type 1 and Type 2 Myotonic Dystrophies
Dozio, E., Passeri, E., Cardani, R., Benedini, S., Aresta, C., Valaperta, R., Romanelli, M. M. C., Meola, G., Sansone, V., & Corbetta, S. (2017) · Frontiers in Endocrinology · doi:10.3389/fendo.2017.00320 · Cited by 16
Serum vitamin D status and circulating irisin levels in older adults with sarcopenia
Wang, Y., Gu, Y., Huang, J. H., Wu, H., Meng, G., Zhang, Q., Liu, L., Zhang, S., Wang, X., Zhang, J., et al. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.1051870 · Cited by 16
Obesity, Osteoarthritis, and Myokines: Balancing Weight Management Strategies, Myokine Regulation, and Muscle Health
Timofte, D. V., Tudor, R. C., Mocanu, V., & Labusca, L. S. (2024) · Nutrients · doi:10.3390/nu16234231 · Cited by 16
A reconciling hypothesis centred on brain-derived neurotrophic factor to explain neuropsychiatric manifestations in rheumatoid arthritis
Pédard, M., Quirié, A., Prigent‐Tessier, A., Garnier, P. E., Totoson, P., Demougeot, C., & Marie, C. (2020) · Rheumatology · doi:10.1093/rheumatology/keaa849 · Cited by 15
Early urea-to-creatinine ratio to predict rapid muscle loss in critically ill patients with sepsis: a single-center retrospective observational study
Jiang, J., Chen, H., Meng, S., Pan, C. S., Xie, J., & Guo, F. (2025) · BMC Anesthesiology · doi:10.1186/s12871-025-02892-8 · Cited by 14
HIF-1α Negatively Regulates Irisin Expression Which Involves in Muscle Atrophy Induced by Hypoxia
Liu, S., Fu, P., Ning, K., Wang, R., Yang, B., Chen, J., & Xu, H. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23020887 · Cited by 14
Targeting Crosstalk of Signaling Pathways among Muscles-Bone-Adipose Tissue: A Promising Therapeutic Approach for Sarcopenia
Sharma, A. R., Chatterjee, S., Lee, Y., & Lee, S. (2023) · Aging and Disease · doi:10.14336/ad.2023.00903 · Cited by 15
Inverse correlation between serum irisin and cardiovascular risk factors among Chinese overweight/obese population
Liu, R., Zhang, Q., Peng, N., Xu, S., Zhang, M., Hu, Y., Chen, Z., Tang, K., He, X., Li, Y., et al. (2021) · BMC Cardiovascular Disorders · doi:10.1186/s12872-021-02380-0 · Cited by 15
Systematic Review and Meta-Analysis of Circulating Irisin Levels Following Endurance Training: Results of Continuous and Interval Training
Cosio, P. L., Peláez, M., Cadefau, J. A., & Farrán-Codina, A. (2022) · Biological Research For Nursing · doi:10.1177/10998004221142580 · Cited by 13
Potential role of irisin in lung diseases and advances in research
Dong, H., Lv, X., Gao, P., & Hao, Y. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1307651 · Cited by 12
Dietary Intervention, When Not Associated With Exercise, Upregulates Irisin/FNDC5 While Reducing Visceral Adiposity Markers in Obese Rats
Furino, V. D. O., Alves, J. M., Marine, D. A., Sene‐Fiorese, M., Rodrigues, C. N. D. S., Arrais-Lima, C., Mattiello, S. M., de Castro, C. A., Borra, R. C., Rocha, M. C., et al. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.564963 · Cited by 10
Irisin: A Possible Marker of Adipose Tissue Dysfunction in Obesity
Tomasello, L., Pitrone, M., Guarnotta, V., Giordano, C. S. D. S., & Pizzolanti, G. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241512082 · Cited by 11
Sarcopenia in children: Lecture
Zavyalova, A. N., Новикова, В. П., & Яковлева, М. Н. (2024) · Meditsinskiy sovet = Medical Council · doi:10.21518/ms2023-470 · Cited by 9
Serum Irisin, Myostatin, and Myonectin Correlate with Metabolic Health Markers, Liver Disease Progression, and Blood Pressure in Patients with Metabolic Dysfunction-Associated Fatty Liver Disease and Hypertension
Sheptulina, A., Mamutova, E. M., Elkina, A. Y., Timofeev, Y. S., Metelskaya, V. A., Kiselev, A., & Drapkina, O. (2024) · Metabolites · doi:10.3390/metabo14110584 · Cited by 8
Impact of acute circuit training on irisin in younger and older overweight adults
Rioux, B. V., Brunt, K. R., Eadie, A. L., B̀ouchard, D. R., Fox, J., & Sénéchal, M. (2021) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/apnm-2020-1087 · Cited by 9
Myokines in Acromegaly: An Altered Irisin Profile
Mizera, Ł., Halupczok-Żyła, J., Kolačkov, K., Zembska, A., Grzegrzółka, J., Jędrzejuk, D., Bolanowski, M., & Daroszewski, J. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.728734 · Cited by 9

Authors: Chang, J. S., Kim, T. H., Nguyen, T. T., Park, K., Kim, N., & Kong, I. D.
Affiliations: Yonsei University (KR)
Department of Physiology Tan Tao University College of Medicine Long An Vietnam
Keimyung University (KR)
Corresponding author: Kong, In Deok
ORCID: Chang, Jae Seung
Kim, Tae Ho
Nguyen, Tuyet Thi
Park, Kyu‐Sang
Kim, Nahyun
Kong, In Deok
Venue: Geriatrics & Gerontology International
Publisher: Wiley
Published: 2017-04-10
Volume: 17
Issue: 11
Pages: 2266-2273
ISSN: 1444-1586 (ISSN-L)
1447-0594
DOI: 10.1111/ggi.13030
OpenAlex: W2606294901
Cited by: 166
References: 33
Citations by year: 2026: 16 · 2025: 30 · 2024: 15 · 2023: 27 · 2022: 29 · 2021: 15 · 2020: 14 · 2019: 9 · 2018: 7 · 2017: 4
FWCI: 6.88
Type: journal article
Language: en
Open access: hybrid
doi.org
Licence: cc-by-nc-nd
creativecommons.org/licenses/by-nc-nd/4.0/ (vor)
Locations: Geriatrics and gerontology international/Geriatrics & gerontology international (publishedVersion, cc-by-nc-nd)
PubMed (publishedVersion)
KUMeL Repository (Keimyung University) (submittedVersion, cc-by-nc-nd)
Funders: Research Grants, Yonsei University Wonju College of Medicine (YUWCM-2013-24)
Topics: Health Sciences › Medicine › Physiology (medical) › Nutrition and Health in Aging
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
Health Sciences › Medicine › Physiology (medical) › Body Composition Measurement Techniques
Keywords: irisin, sarcopenia, myokines, serum biomarkers, muscle weakness, muscle atrophy, Asian Working Group for Sarcopenia criteria, community-dwelling older adults, age-related muscle loss, predictive value
MeSH terms: Cross-Sectional Studies, Female, Fibronectins, Humans, Male, Predictive Value of Tests, Biomarkers, Sarcopenia

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Circulating irisin levels as a predictive biomarker for sarcopenia: a cross-sectional community-based study

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks